NO139560C - Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater - Google Patents
Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivaterInfo
- Publication number
- NO139560C NO139560C NO1481/73A NO148173A NO139560C NO 139560 C NO139560 C NO 139560C NO 1481/73 A NO1481/73 A NO 1481/73A NO 148173 A NO148173 A NO 148173A NO 139560 C NO139560 C NO 139560C
- Authority
- NO
- Norway
- Prior art keywords
- nonapeptidamide
- derivatives
- preparation
- therapeutically effective
- analogical procedure
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP4268672A JPS5324423B2 (fr) | 1972-04-29 | 1972-04-29 | |
JP11845272A JPS5324424B2 (fr) | 1972-11-24 | 1972-11-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
NO139560B NO139560B (no) | 1978-12-27 |
NO139560C true NO139560C (no) | 1979-04-04 |
Family
ID=26382407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO1481/73A NO139560C (no) | 1972-04-29 | 1973-04-10 | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater |
Country Status (17)
Country | Link |
---|---|
US (1) | US3853837A (fr) |
AT (1) | AT333988B (fr) |
AU (1) | AU453931B2 (fr) |
CA (1) | CA1005815A (fr) |
CH (1) | CH580065A5 (fr) |
CS (1) | CS188162B2 (fr) |
DE (2) | DE2321174C2 (fr) |
DK (1) | DK147851C (fr) |
ES (1) | ES414197A1 (fr) |
FI (1) | FI56676C (fr) |
FR (1) | FR2183021B1 (fr) |
GB (1) | GB1403642A (fr) |
HU (1) | HU168696B (fr) |
NL (2) | NL176856C (fr) |
NO (1) | NO139560C (fr) |
PL (1) | PL95790B1 (fr) |
SE (1) | SE397520B (fr) |
Families Citing this family (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3931138A (en) * | 1973-03-13 | 1976-01-06 | Abbott Laboratories | N-carbobenzoxy-pyroglutamyl-histidine |
AT347054B (de) * | 1973-09-29 | 1978-12-11 | Takeda Chemical Industries Ltd | Verfahren zur herstellung von neuen nonapeptidamid-derivaten |
GB1532211A (en) * | 1974-10-25 | 1978-11-15 | Wellcome Found | Lh-rh peptide analogues |
US4338305A (en) * | 1975-03-24 | 1982-07-06 | American Home Products Corporation | Use of LRH and LRH agonists |
AU497512B2 (en) * | 1975-04-15 | 1978-12-14 | Ici Australia Limited | Nona and deca-peptides |
US4034082A (en) * | 1976-03-01 | 1977-07-05 | Abbott Laboratories | Method to prevent reproduction in warm-blooded female animals with nonapeptides |
DE2905502C2 (de) * | 1979-02-14 | 1982-07-15 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Herstellung von LH-RH bzw. LH-RH-Analoga und Pyroglutamyl-N↑i↑m↑-dinitrophenyl-histidin |
DE3020941A1 (de) * | 1980-06-03 | 1981-12-17 | Hoechst Ag, 6000 Frankfurt | Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung |
US4675189A (en) * | 1980-11-18 | 1987-06-23 | Syntex (U.S.A.) Inc. | Microencapsulation of water soluble active polypeptides |
US4659696A (en) * | 1982-04-30 | 1987-04-21 | Takeda Chemical Industries, Ltd. | Pharmaceutical composition and its nasal or vaginal use |
HU193607B (en) * | 1985-07-18 | 1987-11-30 | Innofinance Altalanos Innovaci | Process for production of sexual products applyable for natural or artificial insemination for mammates |
US4897268A (en) * | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
US5068221A (en) * | 1989-05-09 | 1991-11-26 | Mathias John R | Treatment of motility disorders with a gnrh analog |
JP2653255B2 (ja) | 1990-02-13 | 1997-09-17 | 武田薬品工業株式会社 | 長期徐放型マイクロカプセル |
CA2050425A1 (fr) | 1990-09-03 | 1992-03-04 | Yoshiaki Uda | Composition pharmaceutique et son utilisation avec du mucus |
NO302481B1 (no) | 1990-10-16 | 1998-03-09 | Takeda Chemical Industries Ltd | Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring |
US5434136A (en) * | 1990-12-14 | 1995-07-18 | Mathias; John R. | Treatment of motility disorders with a GNRH analog |
US5518730A (en) * | 1992-06-03 | 1996-05-21 | Fuisz Technologies Ltd. | Biodegradable controlled release flash flow melt-spun delivery system |
ES2110573T3 (es) | 1992-08-07 | 1998-02-16 | Takeda Chemical Industries Ltd | Produccion de microcapsulas de farmacos solubles en agua. |
US5594091A (en) * | 1994-02-21 | 1997-01-14 | Takeda Chemical Industries, Ltd. | Matrix for sustained-release preparation |
US6117455A (en) * | 1994-09-30 | 2000-09-12 | Takeda Chemical Industries, Ltd. | Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent |
US5837281A (en) | 1995-03-17 | 1998-11-17 | Takeda Chemical Industries, Ltd. | Stabilized interface for iontophoresis |
US6413536B1 (en) | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
US7833543B2 (en) * | 1995-06-07 | 2010-11-16 | Durect Corporation | High viscosity liquid controlled delivery system and medical or surgical device |
CA2192782C (fr) | 1995-12-15 | 2008-10-14 | Nobuyuki Takechi | Production de microsphere |
CA2192773C (fr) | 1995-12-15 | 2008-09-23 | Hiroaki Okada | Obtention d'une preparation a liberation prolongee pour injection |
US5908400A (en) * | 1996-06-20 | 1999-06-01 | Hisamitsu Pharmaceutical Co., Inc. | Device structure for iontophoresis |
US6051558A (en) * | 1997-05-28 | 2000-04-18 | Southern Biosystems, Inc. | Compositions suitable for controlled release of the hormone GnRH and its analogs |
US20060025328A1 (en) * | 1997-05-28 | 2006-02-02 | Burns Patrick J | Compositions suitable for controlled release of the hormone GnRH and its analogs |
EP0882736A1 (fr) * | 1997-06-02 | 1998-12-09 | Laboratoire Theramex S.A. | Analogues peptidiques du LH-RH, leurs utilisations et compositions pharmaceutiques les contenant |
JP4414517B2 (ja) | 1999-09-01 | 2010-02-10 | 久光製薬株式会社 | イオントフォレーシス用デバイス構造体 |
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
CN101797221B (zh) | 2002-12-13 | 2013-06-12 | 杜雷科特公司 | 包含高粘度液体载体材料的口服递药系统 |
SI2767292T1 (sl) | 2004-09-17 | 2017-01-31 | Durect Corporation | Pripravek, ki vsebuje lokalni anestetik SAIB, s podaljšanim sproščanjem |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
ES2388355T3 (es) | 2006-11-03 | 2012-10-11 | Durect Corporation | Sistemas de suministro transdémico que comprenden bupivacaína |
AU2008347158B8 (en) | 2007-12-06 | 2013-08-22 | Durect Corporation | Oral pharmaceutical dosage forms |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
WO2014144975A1 (fr) | 2013-03-15 | 2014-09-18 | Durect Corporation | Compositions ayant un agent de modification rhéologique pour réduire une variabilité de dissolution |
CN115666621A (zh) | 2020-01-13 | 2023-01-31 | 度勒科特公司 | 具有减少的杂质的持续释放药物递送系统及相关方法 |
-
1973
- 1973-04-10 NO NO1481/73A patent/NO139560C/no unknown
- 1973-04-18 AU AU54676/73A patent/AU453931B2/en not_active Expired
- 1973-04-25 US US00354381A patent/US3853837A/en not_active Expired - Lifetime
- 1973-04-25 DK DK225073A patent/DK147851C/da not_active IP Right Cessation
- 1973-04-25 FR FR7315044A patent/FR2183021B1/fr not_active Expired
- 1973-04-26 DE DE2321174A patent/DE2321174C2/de not_active Expired
- 1973-04-26 SE SE7305905A patent/SE397520B/xx unknown
- 1973-04-26 DE DE2366379A patent/DE2366379C2/de not_active Expired
- 1973-04-27 FI FI1375/73A patent/FI56676C/fi active
- 1973-04-27 CS CS733045A patent/CS188162B2/cs unknown
- 1973-04-27 AT AT377173A patent/AT333988B/de not_active IP Right Cessation
- 1973-04-27 CA CA169,683A patent/CA1005815A/en not_active Expired
- 1973-04-27 NL NLAANVRAGE7305995,A patent/NL176856C/xx active Protection Beyond IP Right Term
- 1973-04-27 CH CH606673A patent/CH580065A5/xx not_active IP Right Cessation
- 1973-04-28 HU HUTA1249A patent/HU168696B/hu unknown
- 1973-04-28 PL PL1973162210A patent/PL95790B1/pl unknown
- 1973-04-28 ES ES414197A patent/ES414197A1/es not_active Expired
- 1973-04-30 GB GB2042773A patent/GB1403642A/en not_active Expired
-
1993
- 1993-02-04 NL NL930004C patent/NL930004I1/nl unknown
Also Published As
Publication number | Publication date |
---|---|
FR2183021A1 (fr) | 1973-12-14 |
US3853837A (en) | 1974-12-10 |
AU5467673A (en) | 1974-10-17 |
ES414197A1 (es) | 1976-05-01 |
NO139560B (no) | 1978-12-27 |
CA1005815A (en) | 1977-02-22 |
DK147851C (da) | 1986-03-10 |
HU168696B (fr) | 1976-06-28 |
CS188162B2 (en) | 1979-02-28 |
DK147851B (da) | 1984-12-24 |
AU453931B2 (en) | 1974-10-17 |
FI56676B (fi) | 1979-11-30 |
SE397520B (sv) | 1977-11-07 |
DE2321174C2 (de) | 1982-04-15 |
AT333988B (de) | 1976-12-27 |
NL176856C (nl) | 1985-06-17 |
DE2366379C2 (de) | 1985-01-17 |
PL95790B1 (pl) | 1977-11-30 |
NL7305995A (fr) | 1973-10-31 |
ATA377173A (de) | 1976-04-15 |
DE2321174A1 (de) | 1973-11-08 |
FI56676C (fi) | 1980-03-10 |
FR2183021B1 (fr) | 1976-04-09 |
CH580065A5 (fr) | 1976-09-30 |
GB1403642A (en) | 1975-08-28 |
NL930004I1 (nl) | 1993-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO139560C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater | |
NO793013L (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater | |
NO140059B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinderivater | |
NO137694C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner | |
NO140058C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater | |
NO138999C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner | |
NO142303C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme oksazolderivater | |
NO138599C (no) | Analogifremgangsmaate til fremstilling av nye, terapeutisk virksomme tienopyrimidinderivater | |
NO139861C (no) | Fremgangsmaate til fremstilling av 1-hydroksy-2-pyridoner | |
NO137858C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner | |
NO140670C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater | |
NO138063C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater | |
NO137728C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater | |
NO138025C (no) | Analogifremgangsmaate til fremstilling av antimykotisk virksomme 1-etyl-imidazoler | |
NO139050C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater | |
NO138251C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer | |
NO137752C (no) | Analogifremgangsmaater til fremstilling av forbindelser med antiarrytmisk virkning | |
NO138375C (no) | Analogifremgangsmaate til fremstilling av terapeutisk virksomme cefalosporinderivater | |
NO140299C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner | |
NO137727C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 1-fenyl-3-hydroksy-3-metyltriazener | |
NO137695C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser | |
SE403112B (sv) | Analogiforfarande for framstellning av skopolaminderivat | |
NO137998C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tebain- og oripavin-derivater | |
NO139440C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive 2-amino-4h-pyraner | |
NO137696C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzodiazepin-derivater |